Table 2 Patient-related outcomes at baseline and follow-up: descriptive summary

Generalised anxiety disorder assessment (GAD7)

Range 0 to 21 (minimal anxiety to severe anxiety)

8.2 (4.8)

28

8.8 (4.2)

29

5.7 (4.8)

24

8.4 (5.9)

22

6.8 (5.7)

23

7.8 (5.3)

22

Quick inventory of depressive symptomatology–self report (QIDS-SR)

Range 0 to 37 (higher score indicates higher depressive symptoms)

9.6 (5.2)

28

9.6 (4.7)

29

6.8 (4.0)

25

10.0 (5.6) 22

7.7 (5.0)

23

9.6 (5.6)

22

Altman Self-Rating Scale for Mania (ASRM)

Range 6 to 20 (higher score indicates increased manic symptoms)

3.5 (3.6)

28

2.1 (2.1)

29

2.4 (2.3)

25

1.5 (2.0)

23

2.9 (4.2)

23

1.5 (2.1)

22

EuroQol EQ-5D-5L—index

Range -0.594 to 1.0 (0 indicates death and 1 indicates perfect health)

0.66 (0.25) 28

0.62 (0.31) 29

0.73 (0.25) 25

0.61 (0.29) 23

0.71 (0.62) 25

0.67 (0.33) 23

EuroQol EQ-5D-5L—VAS

Range 0 to 100 (0 indicates death and 100 indicates perfect health)

59.5 (21.2) 28

55.6 (21.1) 29

64.7 (24.6) 25

61.9 (22.4) 23

62.6 (22.0) 25

61.0 (19.5) 23

ICEpop CAPability measure for Adults (ICECAP-A)

Range 0 to 1.0 (0 indicates no capacity and 1 indicates full capacity)

0.65 (0.21) 28

0.70 (0.23) 29

0.77 (0.69) 25

0.67 (0.26) 23

0.75 (0.22) 25

0.74 (0.19) 23

Oxford CAPabilities questionnaire-Mental health (OxCAP-MH)

range 16 to 80 standardised to 0 to 100 (0 indicates no capability and 100 maximum capability)

56.0 (10.3) 27

59.0 (8.4) 29

61.7 (8.9) 25

58.7 (8.2) 23

57.7 (9.4) 25

57.2 (8.2) 23